Skip to main content

Table 1 Patient clinical characteristics

From: Surgical treatment of chronic pulmonary aspergillosis using preventive latissimus dorsi muscle flaps

Variable Total With flap Without flap p
Age (years), mean ± SD 65 ± 8 65 ± 7 66 ± 9 0.824
Sex (Male/Female) 14/2 6/0 8/2 0.500
Smoking status (Current/Former/Never) 10/2/4 3/0/3 7/2/1 0.108
Smoking index (pack-year), mean ± SD 31 ± 26 18 ± 20 39 ± 27 0.130
Body mass index (<18.5/≥ 18.5) 6/10 3/3 3/7 0.607
Performance status (0/1/2/3) 13/1/2/0 4/1/1 9/0/1 0.309
Underlying lung disorders (Tbc/others/none) 9/4/3 3/1/2 6/3/1 0.498
 Tuberculosis 9 3 6  
 Chronic obstructive pulmonary disease 6 1 5  
 Pneumothorax 3 1 2  
 Idiopathic pulmonary fibrosis 1 0 1  
 Lung cancer 1 1 0  
 None 3 2 1  
Comorbidity (diabetes mellitus/others) 10/6 4/2 6/4 1.000
 Diabetes mellitus 10 4 6  
 Chronic renal failure 2 1 1  
 Othersa 5 2 3  
 None 0 0 0  
Location; RUL/LUL 10/6 3/3 7/3 0.607
Size of fungus ball (cm), mean ± SD 3.4 ± 1.4 3.9 ± 1.9 3.1 ± 1.1 0.262
Type of aspergilloma (simple/complex) 1/15 6/0 9/1 1.000
Preoperative antifungal therapy 13/3 6/0 7/3 0.250
Preoperative bronchial artery embolization 9/7 4/2 5/5 0.633
  1. SD standard deviation; aOthers = liver cirrhosis, ulcerative colitis with steroid use, Marfan syndrome, dilated cardiomyopathy, and gastric cancer